What is Theator?
Founded in 2018 and headquartered in Palo Alto, California, Theator operates at the intersection of artificial intelligence and surgical excellence. The platform is engineered to address the persistent challenges of variability and disparity in surgical care by providing surgeons with deep, objective insights derived from their own procedures. By partnering with leading hospitals, professional societies, and research institutions, Theator is transforming the operating room into a transparent, learning environment. The company's core value proposition lies in its ability to empower surgeons to refine their expertise, ultimately driving higher standards of patient safety and operational efficiency across diverse medical settings.
How much funding has Theator raised?
Theator has raised a total of $42.5M across 1 funding round:
Series A
$42.5M
Series A (2022): $42.5M with participation from Blumberg Capital L.L.C, Mayo Clinic, Blumberg Capital Partners, and Insight Partners
Key Investors in Theator
Mayo Clinic
Mayo Clinic is a nonprofit global healthcare organization specializing in integrated clinical practice, education, and medical research, bringing together specialists to address complex health conditions.
Insight Partners
Insight Partners is a global venture capital and private equity firm that invests in high-growth technology and software companies, providing extensive operational support through its dedicated portfolio network.
Blumberg Capital Partners
Blumberg Capital is an early-stage venture capital firm that partners with visionary entrepreneurs to build successful technology companies, focusing on transformative innovations in the enterprise and healthcare sectors.
What's next for Theator?
With this latest capital injection, Theator is poised to scale its operations and deepen its integration within major hospital networks. The strategic focus will likely center on expanding the platform's analytical capabilities and broadening its reach to include more specialized surgical disciplines. As the company transitions into its next phase of growth, the emphasis will remain on fostering partnerships that enhance the transparency and efficacy of surgical care. By continuing to invest in its proprietary technology, Theator aims to set a new benchmark for surgical intelligence, ensuring that data-driven insights become a standard feature of the modern operating room.
See full Theator company page
